Sexual Functioning After Primary Treatment of Ovarian Cancer

Memorial Sloan Kettering Cancer Center (MSK)

Status

Terminated

Conditions

Sexual Dysfunction

Ovarian Cancer

Treatments

Behavioral: questionnaires

Study type

Observational

Funder types

Other

Identifiers

NCT00596544

04-124

Details and patient eligibility

About

The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer.

How common are sexual problems after treatment for ovarian cancer?

What factors make women more likely to have sexual problems after treatment for ovarian cancer?
What happens to sexual functioning over the first 12 months after treatment? ie.

Does it get better or worse?

• Does referral to a specialized sexual health clinic help?

Enrollment

18 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months
Women must have no clinical evidence of disease
At least 18 years of age
English speaking
Able to participate in the informed consent process
Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC.

Exclusion criteria

Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment
Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination
Women with borderline (low malignant potential) ovarian cancers
Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic
Women with a history of prior whole pelvic radiation